Immune Checkpoint Inhibitor-Induced (Type 3) Autoimmune Pancreatitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11894-023-00885-6.pdf
Reference32 articles.
1. Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223–49. https://doi.org/10.1146/annurev-pathol-042020-042741.
2. •• Sayed Ahmed A, Abreo M, Thomas A, Chari ST. Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis). Curr Opin Gastroenterol. 2022;38(5):516–20. https://doi.org/10.1097/MOG.0000000000000873. This paper provides a comprehensive overview on this novel form of drug induced, immune mediated chronic pancreatic injury- type 3 AIP.
3. •• Thomas AS, Abreo M, Sayed SA, Sireesha Yedururi YW, Chari ST. Autoimmune pancreatitis secondary to Immune checkpoint inhibitor therapy (type 3 AIP): insights into a new disease from serial pancreatic imaging. Gastroenterology. 2023;164(1):154–5. https://doi.org/10.1053/j.gastro.2022.09.042. This retrospective analysis provides insight into the radiological patterns of type 3 AIP as well as the short term radiologic profile of this form of chronic pancreatic injury in the largest database of patients with type 3 AIP.
4. George J, et al. Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: a systematic review and meta-analysis. Pancreatology. 2019;19(4):587–94.
5. Su Q et al. Risk of immune-related pancreatitis in patients with solid tumors treated with immune checkpoint inhibitors: systematic assessment with meta-analysis. J Immunol Res. 2018;2018:1027323.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment approaches in autoimmune pancreatitis (Review);Biomedical Reports;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3